First-line Ribociclib Plus Endocrine Therapy May Be More Effective Than Combination Chemotherapy in Patients With Aggressive Breast Cancer
Patients were pre- or perimenopausal with hormone receptor-positive, HER2-negative tumors SAN ANTONIO – In patients with hormone receptor-positive, HER2-negative,...